Extending the stroke treatment window beyond DAWN in patients with very slow progressor type collaterals: How far can we go?

Five trials published in 2015 showed the benefit of endovascular thrombectomy (ET) in patients with stroke and large vessel occlusion, extending the treatment window has become an obsession of all physicians. In 2018, the DAWN and DEFUSE-3 trials showed that, with careful selection of patients, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagiola, Igor, Chassin, Olivier, Gallas, Sophie, Riviere, Mariana Sarov, Legris, Nicolas, Mihalea, Cristian, Caroff, Jildaz, Ikka, Leon, Chalumeau, Vanessa, de Aguiar, Guilherme Brasileiro, Ozanne, Augustin, Moret, Jacques, Denier, Christian, Spelle, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Cerebrovascular Surgeons and Korean NeuroEndovascular Society 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743825/
https://www.ncbi.nlm.nih.gov/pubmed/34915608
http://dx.doi.org/10.7461/jcen.2021.E2021.01.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743825/
https://www.ncbi.nlm.nih.gov/pubmed/34915608
http://dx.doi.org/10.7461/jcen.2021.E2021.01.003

Ejemplares similares